| Price | 1,511.50p on 13-06-2025 at 18:50:06 |
|---|---|
| Change | -38.00p -2.45% |
| Buy | 1,512.50p |
| Sell | 1,511.50p |
| Buy / Sell GSK Shares | |
| Last Trade: | Sell 62,967.00 at 1,511.50p |
| Day's Volume: | 9,549,371 |
| Last Close: | 1,511.50p |
| Open: | 1,536.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,509.00p - 1,554.00p |
| 52wk Range: | 1,242.50p - 1,678.00p |
| Market Capitalisation: | £61,237m |
| VWAP: | 1,524.57278p |
| Shares in Issue: | 4,051m |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 62,967 | 1,511.50p | SI Trade Suspected SELL Trade |
16:49:22 - 13-Jun-25 |
| Buy* | 12,891 | 1,531.884p | SI Trade Negotiated Trade |
16:47:04 - 13-Jun-25 |
| Buy* | 8,000 | 1,511.50p | Automatic Execution |
16:36:02 - 13-Jun-25 |
| Buy* | 5,800 | 1,511.50p | Automatic Execution |
16:36:01 - 13-Jun-25 |
| Buy* | 100,000 | 1,511.50p | Automatic Execution |
16:35:57 - 13-Jun-25 |
| Buy* | 100,000 | 1,511.50p | Automatic Execution |
16:35:57 - 13-Jun-25 |
| Unknown* | 21,492 | 1,511.50p | OTC Trade |
16:35:23 - 13-Jun-25 |
| Unknown* | 14,019 | 1,511.50p | OTC Trade |
16:35:23 - 13-Jun-25 |
| Unknown* | 11,454 | 1,511.50p | OTC Trade |
16:35:23 - 13-Jun-25 |
| Unknown* | 2,035 | 1,511.50p | OTC Trade |
16:35:23 - 13-Jun-25 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Jun 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Jun 2025 7:00 am | RNS | Transaction in Own Shares |
| 13th Jun 2025 7:00 am | RNS | GSK submits Arexvy for adults 18+ with EMA |
| 12th Jun 2025 11:00 am | PRN | Director/PDMR Shareholding |
| 12th Jun 2025 7:00 am | RNS | Transaction in Own Shares |
| 11th Jun 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 11th Jun 2025 7:00 am | RNS | Transaction in Own Shares |
| 10th Jun 2025 7:00 am | RNS | Transaction in Own Shares |
| 9th Jun 2025 7:00 am | RNS | Transaction in Own Shares |
| 6th Jun 2025 7:00 am | RNS | Transaction in Own Shares |
